On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications ...

Bridging science and religion, forensic researchers spent nearly a decade identifying the remains of a Croatian nun with DNA evidence.

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

Researchers found compounds produced in polar bear skin that were as ice resistant as PFAS, offering potential novel ...

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

Slow temperature recovery can threaten the integrity of your work. That’s Stirling Ultracold designed the VAULT100™ to operate at setpoints down to -100°C, so your samples may never be exposed to ...

The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

Scientists identified molecular targets of polycystic ovarian syndrome in rodents and humans, paving the way for improved ...

Polypharmacology allows scientists to explore novel therapeutic purposes for existing drugs and opens new doors to treat ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Large-bodied animals across the tree of life have evolved unique ways to combat cancer which could inspire novel therapeutic ...